Detalhe da pesquisa
1.
Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells.
Cell Biol Toxicol
; 39(3): 795-811, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34519926
2.
Germline CSF3R Variant in Chronic Myelomonocytic Leukemia: Linking Genetic Predisposition to Uncommon Hemorrhagic Symptoms.
Int J Mol Sci
; 24(22)2023 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38003211
3.
ETV6::ABL1-Positive Myeloid Neoplasm: A Case of a Durable Response to Imatinib Mesylate without Additional or Previous Treatment.
Int J Mol Sci
; 25(1)2023 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38203288
4.
Platelets Contribution to Thrombin Generation in Philadelphia-Negative Myeloproliferative Neoplasms: The "Circulating Wound" Model.
Int J Mol Sci
; 22(21)2021 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34768772
5.
Genetics and Pathogenetic Role of Inflammasomes in Philadelphia Negative Chronic Myeloproliferative Neoplasms: A Narrative Review.
Int J Mol Sci
; 22(2)2021 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33429941
6.
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia.
Eur J Haematol
; 105(1): 47-55, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32145118
7.
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib.
Am J Hematol
; 92(8): 797-805, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28466557
8.
Inverse regulation of bridging integrator 1 and BCR-ABL1 in chronic myeloid leukemia.
Tumour Biol
; 37(1): 217-25, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26194865
9.
Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients.
Haematologica
; 101(10): 1200-1207, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27470600
10.
Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain.
Blood
; 122(9): 1634-48, 2013 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-23794064
11.
Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemia.
Haematologica
; 100(9): 1146-50, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26113419
12.
Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukemia.
Biol Blood Marrow Transplant
; 19(5): 735-40, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23333776
13.
Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation Sequencing.
Biomedicines
; 11(2)2023 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36830896
14.
Uncovering the expression of circPVT1 in the extracellular vesicles of acute myeloid leukemia patients.
Biomed Pharmacother
; 165: 115235, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37536029
15.
Genetic regulation of iron homeostasis in sideropenic patients with mild COVID-19 disease under a new oral iron formulation: Lessons from a different perspective.
Immunobiology
; 227(6): 152297, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36327544
16.
Understanding Aberrant Signaling to Elude Therapy Escape Mechanisms in Myeloproliferative Neoplasms.
Cancers (Basel)
; 14(4)2022 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35205715
17.
Droplet Digital PCR for BCR-ABL1 Monitoring in Diagnostic Routine: Ready to Start?
Cancers (Basel)
; 13(21)2021 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771634
18.
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients.
Leuk Res
; 101: 106497, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33385697
19.
Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutations.
Leukemia
; 35(10): 2813-2826, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34193978
20.
Kevetrin induces apoptosis in TP53 wildtype and mutant acute myeloid leukemia cells.
Oncol Rep
; 44(4): 1561-1573, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32945487